Effects of CAR-T Cell Therapy on Immune Cells and Related Toxic Side Effect Analysis in Patients with Refractory Acute Lymphoblastic Leukemia

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Indicators</td><td class="align_center">Grade 1</td><td class="align_center">Grade 2</td><td class="align_center">Grade 3</td><td class="align_center">Grade 4</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Fever</td><td class="align_center">Body temperature ≥ 38°C</td><td class="align_center">Body temperature ≥ 38°C</td><td class="align_center">Body temperature ≥ 38°C</td><td class="align_center">Body temperature ≥ 38°C</td></tr><tr><td class="align_left">Hypotension</td><td class="align_center">No</td><td class="align_center">No need to use antihypertensive drugs</td><td class="align_center">1 antihypertensive drug is required, with or without vasopressin</td><td class="align_center">Multiple antihypertensive drugs are required (excluding vasopressin)</td></tr><tr><td class="align_left"></td><td class="align_left"></td><td class="align_center">And/or</td><td class="align_left"></td><td class="align_left"></td></tr><tr><td class="align_left">Hypoxemia</td><td class="align_center">No</td><td class="align_center">Need low flow nasal catheter oxygen inhalation</td><td class="align_center">Need high flow nasal catheter oxygen inhalation and circulatory respirator</td><td class="align_center">Need positive pressure ventilation</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Mediators of Inflammation

tab1

Table 1

Table 1: Effects of CAR-T Cell Therapy on Immune Cells and Related Toxic Side Effect Analysis in Patients with Refractory Acute Lymphoblastic Leukemia 

Table 1 | Effects of CAR-T Cell Therapy on Immune Cells and Related Toxic Side Effect Analysis in Patients with Refractory Acute Lymphoblastic Leukemia 